Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesSmall changes in six-minute walk distance are important in diffuse parenchymal lung disease
Respiratory Medicine, 09/08/09
Holland AE et al. – Small differences in six–minute walk distance, in the range 29–34m, may be clinically significant for people with diffuse parenchymal lung disease.
Related Articles
Routine placement of an intercostal chest drain during video-assisted thoracoscopic surgical lung biopsy unnecessarily prolongs in-hospital length of stay in selected patients
European Journal of Cardio-Thoracic Surgery, 10/14/09
Relevance Score: 80%
Lung parenchymal involvement and sputum bacteriology in tuberculous pelurisy: correlation with pleural fluid biochemical parameters
Archives of Medical Science, 11/03/09
Relevance Score: 79%
Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts
Arthritis & Rheumatism, 11/11/09
Relevance Score: 69%
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 68%
Radiochemotherapy in small-cell lung cancer
Expert Review of Anticancer Therapy, 10/20/09
Relevance Score: 68%
Today in Restrictive Lung Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis: a Population-Based Study
Chest, 09/30/09
Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia
Respiratory Medicine, 10/06/09
Interstitial lung disease and sleep: What is known
Sleep Medicine, 09/23/09
Sponsor
Article Search
Sponsor